Peptide Therapeutics Market Size, Share, Industry Trends and Forecast to 2030

1. Market Size & CAGR of Peptide Therapeutics Market in 2021

The global peptide therapeutics market size in 2021 was valued at USD 23.4 billion with a compound annual growth rate (CAGR) of 7.2%. The market is expected to reach USD 36.9 billion by 2026. The increasing prevalence of chronic diseases, advancements in peptide therapeutics, and growing investments in R&D are contributing to the market's growth.

2. COVID-19 Impact on the Peptide Therapeutics Market

The COVID-19 pandemic had a mixed impact on the peptide therapeutics market. While there was a disruption in the supply chain and clinical trials, the demand for peptide-based drugs increased due to their potential in treating COVID-19 and other respiratory diseases. The market witnessed a surge in research activities and collaborations to develop peptide therapeutics for combating the pandemic.

3. Peptide Therapeutics Dynamics

Peptide therapeutics are short chains of amino acids that play a crucial role in regulating various biological functions in the body. They are increasingly being used in the treatment of cancer, metabolic disorders, and autoimmune diseases. The market dynamics are influenced by factors such as increasing R&D investments, technological advancements, and the rising prevalence of chronic diseases.

4. Segments and Related Analysis

The peptide therapeutics market is segmented based on type, application, and end-user. The market is further categorized into insulin, vasopressin, calcitonin, immunopeptide, and others. In terms of application, the market is divided into oncology, metabolic disorders, cardiovascular diseases, and others. Hospitals, clinics, and research institutes are the primary end-users of peptide therapeutics.

5. By Region Analysis

The global peptide therapeutics market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market due to the presence of key market players, technological advancements, and high healthcare expenditure. However, the Asia Pacific region is expected to witness significant growth in the coming years due to the increasing prevalence of chronic diseases and growing healthcare infrastructure.

6. Key Market Players and Competitive Landscape

Some of the key players in the peptide therapeutics market include Amgen Inc., AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, and Pfizer Inc. These companies are focusing on research and development activities, strategic collaborations, and mergers and acquisitions to strengthen their market position and expand their product portfolio. The competitive landscape of the market is characterized by intense competition, innovative product launches, and regulatory approvals.

7. Recent Happenings in the Peptide Therapeutics Market

In recent years, the peptide therapeutics market has witnessed several developments such as product launches, strategic partnerships, and regulatory approvals. For example, in 2021, Novo Nordisk received FDA approval for its GLP-1 receptor agonist for the treatment of obesity. Additionally, AstraZeneca entered into a collaboration with a biotech company to develop novel peptide-based therapies for autoimmune diseases. These developments indicate the growing potential and interest in peptide therapeutics for a wide range of disorders.